NGL Fine-Chem Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
NGLFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
NGL Fine-Chem Limited reported strong full-year results for FY2026. Consolidated revenue from operations grew 36% to Rs. 50,095.47 lakhs from Rs. 36,825.67 lakhs in FY2025. Net profit after tax surged 128% to Rs. 4,812.67 lakhs from Rs. 2,112.43 lakhs. On standalone basis, revenue grew 36% to Rs. 48,877.38 lakhs and PAT jumped 130% to Rs. 4,163.22 lakhs. The Board recommended a final dividend of Rs. 1.75 per share (Rs. 108.12 lakhs total). The statutory auditors issued an unmodified (clean) opinion with no qualifications. Capital work-in-progress increased significantly to Rs. 9,456.72 lakhs from Rs. 4,972.58 lakhs, indicating ongoing expansion. The company reappointed two key directors subject to shareholder approval.
The strong 36% revenue growth and 128% PAT growth are positive signals for shareholders. The clean audit report and dividend recommendation reinforce financial stability. The significant increase in capital work-in-progress suggests the company is investing for future growth in the pharmaceuticals segment.